These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14127109)

  • 1. [BIOCHEMICAL FINDINGS ON VARIOUS PROPERTIES OF PHOSPHOCREATINE IN THE CLINICAL FIELD].
    ANGELINO PF; VACCA G
    Minerva Med; 1964 Jan; 55():83-7. PubMed ID: 14127109
    [No Abstract]   [Full Text] [Related]  

  • 2. GLYCOGEN, CREATINE, AND HIGH ENERGY PHOSPHATE IN HUMAN MUSCLE DISEASE.
    VIGNOS PJ; WARNER JL
    J Lab Clin Med; 1963 Oct; 62():579-90. PubMed ID: 14080857
    [No Abstract]   [Full Text] [Related]  

  • 3. [MUSCULAR DYSTROPHY OF THE DUCHENNE TYPE: ENZYMATIC ACTIVITY IN A FAMILIAL GROUP OF SUBJECTS WITH AND WITHOUT CLINICAL MANIFESTATIONS].
    MARZUOLI U; RUBINO R; BOCCALATTE G
    Minerva Med; 1965 Jan; 56():90-2. PubMed ID: 14248694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 5. [Elevation of the serum aldolase level; biochemical test in myopathy].
    SCHAPIRA G; DREYFUS JC; SCHAPIRA F
    Sem Hop; 1953 Jun; 29(38):1917-20. PubMed ID: 13076471
    [No Abstract]   [Full Text] [Related]  

  • 6. [BEHAVIOR OF THE ACHILLES REFLEXOGRAM IN THE AGED PATIENT AND ITS VARIATIONS AFTER TREATMENT WITH PHOSPHOCREATINE].
    SARTONI P; BOTTARELLI E; POMA C
    Minerva Med; 1964 Sep; 55():2827-30. PubMed ID: 14204033
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE BEHAVIOR OF SERUM ALDOLASE AND TRANSAMINASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER ANABOLIC AND RE-METABOLIZING THERAPY].
    BUSCAINO GA; SEPE O
    Acta Neurol (Napoli); 1964; 19():523-46. PubMed ID: 14208396
    [No Abstract]   [Full Text] [Related]  

  • 8. EFFECTS OF STEROIDS ON THE COURSE OF HEREDITARY MUSCULAR DYSTROPHY IN MICE.
    DOWBEN RM; ZUCKERMAN L; GORDON P; SNIDERMAN SP
    Am J Physiol; 1964 May; 206():1049-56. PubMed ID: 14208939
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of serum transaminase and aldolase levels in the course of myopathy].
    BRETON A; GAUDIER B; TRAISNEL M; PONTE C
    Pediatrie; 1960; 15():19-25. PubMed ID: 13804277
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum ATP: creatine phosphotransferase in skeleto-muscular disorders with special reference to duchenne muscular dystrophy.
    Griffiths PD
    Guys Hosp Rep; 1965; 114(4):401-20. PubMed ID: 5859368
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum enzyme changes in muscle disease and their relation to tissue change.
    HUGHES BP
    Proc R Soc Med; 1963 Mar; 56(3):179-82. PubMed ID: 13955533
    [No Abstract]   [Full Text] [Related]  

  • 12. [ADOLASE ACTIVITY IN A MYOPATHY IN A CHILD].
    GORBACHEVA FE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():958-60. PubMed ID: 14103865
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum aldolase in muscular dystrophies, neuromuscular disorders, and wasting of skeletal muscle.
    ROWLAND LP; ROSS G
    AMA Arch Neurol Psychiatry; 1958 Aug; 80(2):157-61. PubMed ID: 13558771
    [No Abstract]   [Full Text] [Related]  

  • 14. FRUCTO-ALDOLASE IN RELATION TO MUSCULAR DYSTROPHIES.
    Mink JK; Greebe HM
    Acta Neurol Scand; 1964; 40(2):107-14. PubMed ID: 14131788
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDY OF SIDEREMIA, ALDOLASEMIA AND TRANSMINASEMIA IN MORE THAN 100 MYOPATHIC PATIENTS IN BASIC CONDITIONS AND AFTER RE-METABOLIZING THERAPY].
    BUSCAINO GA; SPADETTA V; SEPE O
    Rass Med Sarda; 1964; 66():143-55. PubMed ID: 14221414
    [No Abstract]   [Full Text] [Related]  

  • 16. STUDIES ON CARBOHYDRATE METABOLISM IN MUSCULAR DISEASES IN CONDITIONS OF ISCHAEMIC WORK.
    IONASESCU V; LUCA N
    Psychiatr Neurol (Basel); 1965; 149():375-86. PubMed ID: 14334472
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the increase of aldolase in blood in muscular dystrophy].
    GENTILI C
    Clin Pediatr (Bologna); 1959 Sep; 41():736-9. PubMed ID: 13827330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aldolase activity of the blood in patients with progressive muscular dystrophy].
    BERGAMI PL; ZANOLI S
    Chir Organi Mov; 1959; 47():430-4. PubMed ID: 13799247
    [No Abstract]   [Full Text] [Related]  

  • 19. Aldolase activity in the plasma or serum of normal children and families with muscular dystrophy.
    CLAYTON BE; WILSON KM; CARTER CO
    Arch Dis Child; 1963 Jun; 38(199):208-14. PubMed ID: 14021638
    [No Abstract]   [Full Text] [Related]  

  • 20. [DIFFERENTIAL DIAGNOSTIC CONSIDERATIONS IN A CASE OF MUSCULAR DISEASE].
    FORTUYN JD
    Ned Tijdschr Geneeskd; 1964 Jul; 108():1293-6. PubMed ID: 14177184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.